MoneyWorks4Me

Alembic Pharmaceuticals informs about investor presentation

07 Nov 2023 Evaluate
Alembic Pharmaceuticals has enclosed the Investors Presentation on the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2023.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..